Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
CodeSystem: Kenya Medication Administration Route Code System
Codes for the route by which oncology medications are administered.
This Code system is referenced in the definition of the following value sets:
This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs defines the following codes:
| Code | Display | Definition |
| IV-BOLUS |
Intravenous Bolus |
Direct IV injection over <5 minutes. |
| IV-PUSH |
Intravenous Push |
IV injection over 5–15 minutes. |
| IV-INFUSION-SHORT |
IV Short Infusion |
IV infusion over 15 minutes to 3 hours. |
| IV-INFUSION-LONG |
IV Long Infusion |
IV infusion over >3 hours or continuous infusion. |
| ORAL |
Oral |
By mouth (tablets, capsules, solution). |
| SUBCUTANEOUS |
Subcutaneous |
Injection into subcutaneous tissue. |
| INTRAMUSCULAR |
Intramuscular |
Injection into muscle. |
| INTRATHECAL |
Intrathecal |
Into the cerebrospinal fluid (spinal canal). |
| INTRAVESICAL |
Intravesical |
Into the bladder lumen. |
| INTRAPERITONEAL |
Intraperitoneal |
Into the peritoneal cavity. |
| INTRAPLEURAL |
Intrapleural |
Into the pleural cavity. |
| TOPICAL |
Topical |
Applied to skin surface. |
| TRANSDERMAL |
Transdermal |
Through intact skin via patch. |
| INHALED |
Inhaled |
Via inhalation. |
| INTRALESIONAL |
Intralesional |
Injected directly into the lesion. |
| INTRA-ARTERIAL |
Intra-arterial |
Into a feeding artery (e.g., hepatic artery infusion). |
Description of the above table(s).